Eyebright Medical(SH:688050) Shang Hai Zheng Quan Bao·2026-01-20 18:18Core Viewpoint - Aibono Medical (Beijing) Technology Co., Ltd. has signed a Letter of Intent with Demei United (Chongqing) Medical Technology Co., Ltd. to acquire at least 51% of the latter's equity, aiming to gain control over the company and expand its presence in the sports medicine sector [2][4]. Group 1: Transaction Overview - The acquisition is intended to leverage Aibono Medical's existing strengths in research and management to foster growth in the high-potential sports medicine segment, which is experiencing increasing market demand due to rising health awareness and fitness participation [6][7]. - Demei Medical is recognized as a leading enterprise in sports medicine in China, holding 276 patents and having established modern production and R&D facilities, which enhances its competitive edge [2][12]. - The transaction is not classified as a related party transaction or a major asset restructuring as per regulatory definitions [4][9]. Group 2: Investment Intent and Financial Aspects - The investment will be financed through a combination of acquisition loans and the company's own funds, with the total investment amount to be determined based on due diligence results [8][14]. - The estimated valuation for the acquisition of Demei Medical is projected to be no more than RMB 1 billion, based on the company's technological advancements and business performance [14][15]. - Demei Medical has a comprehensive product line covering pre-surgery prevention, surgical treatment, and post-surgery rehabilitation, positioning it well for future growth in the domestic market, which is currently dominated by imported products [6][11]. Group 3: Strategic Implications - The acquisition aligns with Aibono Medical's dual strategy of internal growth and external expansion, aiming to cultivate new profit growth points and solidify long-term performance [7][15]. - The transaction is expected to enhance Aibono Medical's operational synergies in R&D, manufacturing, and sales channels, thereby improving overall performance and shareholder returns [15].